Australia Stock Exchange release from UNIVERSAL BIOSEN : UBI launches Regulatory Clinical Trial for Xprecia Prime
26/10/2021 23:34
Australia Stock Exchange release from UNIVERSAL BIOSEN UBI.AX : UBI launches Regulatory Clinical Trial for Xprecia Prime
Recent news on Universal Biosensors
See all newsBrief: Universal Biosensors Seeks Trading Halt Pending Announcement On Financial Position & Funding
Brief: Universal Biosensors Signs Non-Binding Term Sheet For A$8.5M Funding
Brief: Universal Biosensors Seeks Trading Halt
Brief: Universal Biosensors Inc Posts Qtrly Total Revenue A$1.6 Million
Brief: Universal Biosensors Says John Sharman Steps Down As Managing Director And CEO